Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-25
2006-04-25
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S370000, C544S371000, C544S373000, C514S254090, C514S217080, C514S217090, C514S322000, C514S323000, C548S311700, C548S312100, C546S199000, C546S201000, C540S575000, C540S602000, C540S603000
Reexamination Certificate
active
07034029
ABSTRACT:
The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor
REFERENCES:
patent: 5849759 (1998-12-01), Arnaiz et al.
patent: 5990105 (1999-11-01), Bos et al.
patent: 6251893 (2001-06-01), Maddaford et al.
patent: 6255306 (2001-07-01), Macor
patent: 6288103 (2001-09-01), Faull et al.
patent: WO 98/27081 (1998-06-01), None
patent: WO 99/02502 (1999-01-01), None
patent: WO 02/08178 (2002-01-01), None
patent: WO 02/32863 (2002-04-01), None
Methvin Isaac et al., Bioorganic & Medicinal Chemistry Letters, 2000, 10, 1719-1721
Cole Derek Cecil
Kelly Michael Gerard
Berch Mark L.
Habte Kahsay
Lences Barbara L.
Wyeth
LandOfFree
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3590188